BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14592891)

  • 1. Antibodies in myasthenia gravis and related disorders.
    Vincent A; McConville J; Farrugia ME; Bowen J; Plested P; Tang T; Evoli A; Matthews I; Sims G; Dalton P; Jacobson L; Polizzi A; Blaes F; Lang B; Beeson D; Willcox N; Newsom-Davis J; Hoch W
    Ann N Y Acad Sci; 2003 Sep; 998():324-35. PubMed ID: 14592891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen.
    Matthews I; Sims G; Ledwidge S; Stott D; Beeson D; Willcox N; Vincent A
    Lab Invest; 2002 Oct; 82(10):1407-17. PubMed ID: 12379775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita.
    Vincent A; Jacobson L; Plested P; Polizzi A; Tang T; Riemersma S; Newland C; Ghorazian S; Farrar J; MacLennan C; Willcox N; Beeson D; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():482-96. PubMed ID: 9668280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
    Plested CP; Tang T; Spreadbury I; Littleton ET; Kishore U; Vincent A
    Neurology; 2002 Dec; 59(11):1682-8. PubMed ID: 12473752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
    Farrugia ME; Bonifati DM; Clover L; Cossins J; Beeson D; Vincent A
    J Neuroimmunol; 2007 Apr; 185(1-2):136-44. PubMed ID: 17335909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
    Hong Y; Zisimopoulou P; Trakas N; Karagiorgou K; Stergiou C; Skeie GO; Hao HJ; Gao X; Owe JF; Zhang X; Yue YX; Romi F; Wang Q; Li HF; Gilhus NE; Tzartos SJ
    Eur J Neurol; 2017 Jun; 24(6):844-850. PubMed ID: 28470860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function.
    Riemersma S; Vincent A; Beeson D; Newland C; Hawke S; Vernet-der Garabedian B; Eymard B; Newsom-Davis J
    J Clin Invest; 1996 Nov; 98(10):2358-63. PubMed ID: 8941654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
    Vincent A; Waters P; Leite MI; Jacobson L; Koneczny I; Cossins J; Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1274():92-8. PubMed ID: 23252902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis seronegative for acetylcholine receptor antibodies.
    Vincent A; Leite MI; Farrugia ME; Jacob S; Viegas S; Shiraishi H; Benveniste O; Morgan BP; Hilton-Jones D; Newsom-Davis J; Beeson D; Willcox N
    Ann N Y Acad Sci; 2008; 1132():84-92. PubMed ID: 18567857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis.
    Polizzi A; Huson SM; Vincent A
    Teratology; 2000 Nov; 62(5):332-41. PubMed ID: 11029151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
    Damato V; Spagni G; Monte G; Woodhall M; Jacobson L; Falso S; Smith T; Iorio R; Waters P; Irani SR; Vincent A; Evoli A
    J Neurol Neurosurg Psychiatry; 2022 Sep; 93(9):995-1000. PubMed ID: 35835469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
    Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
    Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.
    Vernet-der Garabedian B; Lacokova M; Eymard B; Morel E; Faltin M; Zajac J; Sadovsky O; Dommergues M; Tripon P; Bach JF
    J Clin Invest; 1994 Aug; 94(2):555-9. PubMed ID: 8040310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.